INTRODUCTION
The viruses that cause acquired immune de¢ciency syndrome (AIDS), human immunode¢ciency virus types 1 and 2 (HIV-1 and HIV-2), are lentiviruses. Their closest relatives, found infecting other primates, are termed simian immunode¢ciency viruses (SIVs) although as far as is known these viruses do not normally cause disease in their natural hosts. More than 20 species of primates, all from sub-Saharan Africa, are known to harbour SIV and at least some of these species exhibit very high rates of infection, with diverse but species-speci¢c viruses. In addition, a number of closely related species of African monkeys are infected by closely related SIVs (Beer et al. 1999) , suggesting that at least some African primates have been infected with SIV for a very long time . In contrast, human infection by HIV-1 and HIV-2 seems a relatively recent phenomenon. For both HIV-1 and HIV-2, the greatest diversity of viral strains, as well as the highest rates of infection, occurs in sub-Saharan Africa (Peeters & Sharp 2000) . These data provide compelling evidence that the HIVs have arisen through cross-species transmission from primates in Africa. Phylogenetic analyses indicate that HIV-1 and HIV-2 fall into two quite di¡erent SIV lineages (¢gure 1) and so have distinct origins.
Strains of SIV closely related to HIV-2 have been isolated from sooty mangabeys (Cercocebus atys) and several macaques (three di¡erent Macaca species). Only a few macaques, all in captivity in North America, have been found to carry these viruses; these species are not naturally infected with SIV in the wild in Asia. In contrast, SIVsm has been isolated from wild sooty mangabeys in western Africa (Chen et al. 1996) . HIV-2 is only endemic in western Africa, and it seems clear that SIVsm has been transmitted to humans there, as well as to macaques in captivity. Detailed consideration of the phylogenetic relationships among SIVsm and HIV-2 strains indicates that cross-species transmission has occurred on multiple occasions (Gao et al. 1992 (Gao et al. , 1994 Chen et al. 1997) .
The only strains of SIV closely related to HIV-1 have been isolated from chimpanzees (Pan troglodytes). The ¢rst of these SIVcpz strains was discovered more than ten years ago (Peeters et al. 1989; Huet et al. 1990 ), but until recently considerable doubt remained as to whether chimpanzees were the natural reservoir of these viruses, because only very few infected animals had been found. There remained the possibility that both humans and chimpanzees became infected from some third sp ecies, an as yet unidenti¢ed African monkey. However, with the at least partial characterization of SIVs from numerous additional primate species , the list of potential candidates for the elusive third species has shrunk considerably. Furthermore, within the last two years, the characterization of additional strains of SIVcpz (Gao et al. 1999; Corbet et al. 2000) , as well as the discovery of a new strain of HIV-1 even more closely related to SIVcpz (Simon et al. 1998) , has strongly tipped the balance in favour of chimpanzees being the immediate source of HIV-1.
But how, where and when did the cross-species transmissions that gave rise to the human AIDS viruses, and in particular HIV-1, occur ? With respect to where and when, molecular evolutionary analyses provide the clearest evidence to answer these questions. With respect to the question how, molecular evolutionary analyses cannot provide an answer, but do at least seem to rule out one proposed route.
HIV-1 DIVERSITY
First it is necessary to review brie£y the diversity of HIV-1. Due to its high replication rate and the errorprone nature of its reverse transcriptase, HIV-1 evolves at an extraordinarily fast rate Korber et al. 1998) , and has accumulated considerable diversity since its arrival in humans. Phylogenetic analyses indicate that the various strains of HIV-1 fall into three groups (Peeters & Sharp 2000) . All of the ¢rst characterized strains, as well as most of those subsequently described, fall into thè main' group, group M, resp onsible for the vast majority of AIDS cases worldwide. This group has been further subdivided into numerous approximately equidistant clades, termed subtypes A^K. Highly divergent strains, forming the`outlier' group, group O, were ¢rst described around ten years ago (De Leys et al. 1990 ). These strains are most commonly found in western equatorial Africa. Most recently, a small number of viruses have been described from Cameroon that belong to a third group (termed N, or`non-M, non-O') (Simon et al. 1998) . Since these three groups are interspersed among lineages of SIVcpz, they must each have arisen from a separate cross-species transmission (Gao et al. 1999; Hahn et al. 2000) .
A second important source of genetic diversity in primate lentiviruses is recombination . The e¡ect of this is most pronounced when a single individual is infected by diverse strains from more than one source. In regions where di¡erent subtypes co-circulate, 10% or more of HIV-1 group M strains are inter-subtyp e recombinants McCutchan 1998; Peeters & Sharp 2000) and recently recombinants of groups M and O have been identi¢ed (Takehisa et al. 1999; Peeters et al. 1999) . Interestingly, group N is also descended from a recombinant strain (Gao et al. 1999; Corbet et al. 2000) ; in this case the recombination event must have occurred in chimpanzees, some time before the transmission of this lineage to humans.
ORIGINS OF HIV-1: HOW?
Chimpanzees (as well as sooty mangabeys, and many other species of primate) are often hunted and butchered for food and sold at major city markets as so called`bushmeat' (Robinson et al. 1999) . Direct exposure of humans to animal blood or mucosal secretions as a result of hunting and ¢eld dressing, or other activities such as consumption of uncooked contaminated meat, would appear to provide the simplest and most plausible explanation for the cross-species transmission of SIVs to become HIVs. However, iatrogenic (i.e. human-induced) modes of cross-species transmission have also been proposed. Among these, the idea that AIDS viruses were transferred from their natural hosts to humans via contaminated preparations of oral polio vaccine (OPV) has recently gained the most widespread attention.
The potential OPV^AIDS link has been mooted on a number of occasions in the past (see, for example, Curtis 1992; Elswood & Stricker 1993) For HIV-1 the group of origin, and for HIV-2 the subtype, are indicated. SIV strains have a su¤x denoting their species of origin: cp z, chimpanzee; lhoest, l'Hoest's monkey; sun, sun-tailed monkey; mnd, mandrill; agm, African green monkey; Ver, vervet; Gri, grivet; Tan, tantalus; mac, macaque; sm, sooty mangabey; syk, Sykes' monkey. See Hahn et al. (2000) for more details.
HIV-2 probably had their origins in polio vaccine preparations from di¡erent laboratories. In particular, the cause of the HIV-1 group M pandemic has been suggested to be the polio vaccine developed by a team led by Dr Hilary Koprowski and administered to roughly one million people in the Belgian Congo, Rwanda and Burundi in the late 1950s. This research group had access to a primate facility at Camp Lindi near Stanleyville (now Kisangani), where locally caught chimpanzees were used for polio vaccine safety testing as well as other research projects. Hooper suggests that kidneys harvested from these apes were used for polio vaccine production in the USA and/or elsewhere, and that kidneys derived from SIVcpz-infected chimpanzees contaminated these OPV preparations (for more detail see Hooper, this issue). While there is no direct evidence to support this scenario, the circumstantial evidence has been presented su¤ciently persuasively to gain some attention, particularly in the lay press (for example, see Ridley 2000) .
Various independent lines of evidence, ranging from serious £aws in the proposed epidemiological linkage of OPV and early AIDS cases, to an almost certain loss of SIV/HIV viability due to the process of vaccine production, undermine the OPV^AIDS scenario. Moreover, testimony from the investigators involved, as well as independent experimental data from the analysis of remaining vaccine samples (which at the very least represent a random sp ot check), argues strongly that chimpanzee kidneys were not used in the vaccine preparation process, and so could not have contaminated it (see other papers in this issue). Our focus is the molecular evolutionary evidence concerning where and when the M group of HIV-1 arose, which is clearly also not consistent with the OPV route. A number of the conclusions from molecular evolutionary analyses have been misinterpreted (Hooper 1999; 2000a,b) and we present the evidence here in greater detail.
ORIGINS OF HIV-1: WHERE?
The source of HIV-1, the common chimpanzee P. troglodytes, is distributed across western and equatorial Africa. Recent genetic evidence, largely from analyses of mitochondrial DNA (mtDNA) sequences, indicates that chimpanzees can be divided into at least two, and perhaps four, distinct subspecies (Morin et al. 1994; Gonder et al. 1997; Gagneux et al. 1999) . Thus chimpanzees from western Africa, termed P. t. verus, are quite distinct from those in equatorial Africa, termed P. t. troglodytes and P. t. schweinfurthii. As yet no example of SIVcpz infection of P. t. verus has been recorded. This may explain the apparent absence of SIVcpz infection among captive chimpanzees outside Africa, since those animals were largely exported from western Africa. There is also some evidence that chimpanzees from Nigeria, which have been termed P. t. vellerosus, are genetically distinct. The only reported instance of SIVcpz infection of P. t. vellerosus was in an animal held in the same facility as an infected P. t. troglodytes: viruses from the two chimpanzees were very closely related, indicating that one animal (presumably the P. t. vellerosus) was the recipient of a cage transmission (Corbet et al. 2000) .
It has long been thought that chimpanzees from equatorial Africa can be divided into two subspecies, the Central chimpanzee P. t. troglodytes from western equatorial Africa (Cameroon, Equatorial Guinea, Gabon and Congo-Brazzaville) and the Eastern chimpanzee P. t. schweinfurthii from Central Africa (northern and eastern Congo, Rwanda, Burundi and western Uganda and Tanzania). From mtDNA analyses, this separation is not so clear, in that chimpanzees from the two putative subspecies do not exhibit reciprocal monophyly: Eastern chimpanzees cluster within the Central chimpanzee radiation. Nevertheless, the extent of mtDNA di¡erentia-tion is such that it seems that most individuals of P. t. schweinfurthii can be identi¢ed with some certainty. Four of the seven known SIVcpz strains clearly came from Central chimpanzees: two from Gabon (Peeters et al. 1989) , and two from Cameroon (Corbet et al. 2000) . A ¢fth came from a wild-born animal held in a primate centre in the USA that was identi¢ed as a Central chimpanzee on the basis of mtDNA analyses (Gao et al. 1999) . Excluding the P. t. vellerosus example, the only SIVcpz strain (SIVcpzAnt) not isolated from a Central chimpanzee came from a wild-caught animal of imprecise Congolese origin, intercepted by Belgian customs o¤cers after illegal export from Kinshasa (Peeters et al. 1992) ; this chimpanzee was identi¢ed as belonging to P. t. schweinfurthii, again on the basis of mtDNA analyses (Gao et al. 1999) . Since all three groups of HIV-1 are more closely related to the SIVcpz strains from Central chimpanzees, we concluded that the cross-species transmissions giving rise to HIV-1 all occurred in western equatorial Africa (Gao et al. 1999 ). This is not consistent with the OPV^AIDS idea, since the chimpanzees at Camp Lindi were almost entirely captured in the northeastern Congo (Courtois 1966) , in the middle of the Eastern chimpanzee range.
In resp onse to the conclusion that Central chimpanzees in western equatorial Africa were the source of all three groups of HIV-1, Hooper has written:`Whereas it [the SIVcpz from Central chimpanzees] is an entirely convincing parent for HIV-1 group N . . . and a slightly less convincing parent for the other minor variant, group O . . . it represents a far from convincing parent for the pandemic variant, group M' (Hooper 2000a, p. 867). However, consideration of the phylogenetic relationships among the SIVcpz strains and the three HIV-1 groups shows that this statement is not supported by existing data. Both groups M and N lie within the radiation of SIVcpz strains from Central chimpanzees (¢gure 2). As discussed above, group N is inferred to be descended from a recombination event among divergent lineages, because its position within phylogenetic trees varies according to the region of genome analysed. Presumably it is the position of group N within the phylogeny derived from Env protein sequences (¢gure 2b) that has convinced Hooper that this group was derived from a Central chimpanzee SIVcpz. In phylogenies derived from the 5 0 half of the genome (such as the Pol gene; ¢gure 2a) group N clusters more closely with group M than with any SIVcpz strain, although both groups M and N lie within the radiation of SIVcpz strains from Central chimpanzees. In this 5 0 region, groups M and N are equidistantly related to SIVcpz from Central chimpanzees, and so if it is
Origins of AIDS viruses P. M. Sharp and others 869 acknowledged that these are`an entirely convincing parent for HIV-1 group N', then they must represent an equally convincing source for group M also. It is also worth noting that while group M strains have spread across all of Africa, now having their highest frequency in the south of the continent and thus outside the range of chimpanzees, the greatest diversity of group M strains is found in western equatorial Africa, i.e. in Kinshasa rather than further east in the Democratic Republic of Congo (Vidal et al. 2000) , consistent with this being their region of origin. (Kinshasa is outside the range of chimpanzees, but is close to the area inhabited by Central chimpanzees, and is by far the largest city in the region.)
Among the three groups of HIV-1, the one that does not fall within the radiation of SIVcpz from Central chimpanzees is group O. Thus on phylogenetic grounds alone, the origin of group O is less certain, although the strains of SIVcpz from Central chimpanzees are the most closely related known viruses for this group also. Since group O strains are most common in, and largely restricted to, Cameroon and neighbouring countries, it is most likely that they too arose from a cross-species transmission in this region.
All currently known SIVcpz strains were derived from chimpanzees that were captured at a young age, most likely (and this is known in several cases) after their parents were killed. Since collection of blood from wild ape populations is not feasible, the prevalence, geographical distribution and extent of diversity of SIVcpz in the wild remain unknown. To investigate this, we have recently developed non-invasive methods to detect SIVcpz antibodies and viral nucleic acids in chimpanzee urine and faecal samples collected in the wild (Santiago et al. 2001) . The sensitivity of antibody detection was tested in captive chimpanzees of known SIVcpz or HIV-1 infection status and found to be 100% for urine and greater than 60% for faeces; in each instance the speci¢city was 100%. The sensitivity of polymerase chain reaction ampli¢cation of viral RNA from faeces of SIVcpz-infected chimpanzees was greater than 50%. Using these assays, we have begun to test chimpanzees from wild communities in western and eastern Africa. While all of the 28 West African chimpanzees tested were negative for SIVcpz antibodies and nucleic acids, 1 out of 30 East African chimpanzees was strongly positive for urine SIVcpz antibodies. This infected individual was one of six chimpanzees sampled from a larger community. Although viral sequences are not yet available, the pro¢le of the Western blot analysis strongly suggests that this strain is not similar to either HIV-1 or SIVcpz from Central chimpanzees. These data demonstrate the feasibility of screening wild chimpanzee populations using entirely non-invasive means and represent, we believe, the ¢rst detection of SIVcpz infection in eastern Africa. Prevalence and molecular epidemiological data of naturally occurring SIVcpz infections (including in the vicinity of Kisangani) can be expected to be forthcoming soon.
ORIGINS OF HIV-1: WHEN?
Consideration of the phylogenetic relationships among HIV-1 and SIVcpz strains (¢gure 2) clearly indicates that each group of HIV-1 represents a separate cross-species transmission event, and that it is most parsimonious to invoke only one such event per group (¢gure 3a). Thus, if the date of the common ancestor within each group can be estimated, this can place a limit (the most recent bound) on the time-scale of when the cross-species transmissions occurred. Attempts to date these events have focused on the M group of HIV-1. Early attempts to place a time-scale on the evolution of the primate lentiviruses gave wildly divergent results (see ). However, after estimating the rate of the molecular clock of HIV-1 it was suggested that the common ancestor of (what is now known as) the M group existed around 1960 . This date seemed to ¢t with knowledge of the early AIDS epidemic, and with the earliest known (retrospectively identi¢ed) antibody-positive serum sample obtained from an individual in Le¨opoldville (now Kinshasa) in 1959 (Nahmias et al. 1986 ). This impression of the time-scale became established (for example, Myers & Korber 1994) , and remained largely unchallenged for nearly ten years. This time-scale would have been consistent with the OPV^AIDS hypothesis.
However, it has become apparent in recent years that the time-depth of the M group radiation has been severely underestimated. Two lines of evidence point to this. First, sequences were obtained from the 1959 sample. When this virus (ZR59) was placed within the HIV-1 evolutionary tree, it was found to lie within the M group on the subtype D lineage, after its split from subtype B (Zhu et al. 1998) , with the clear implication that the common ancestor of the entire M group must have existed rather earlier. Second, it became apparent that the estimate of 1960 had been derived from an analysis that assumed an oversimplistic model of nucleotide sequence evolution. In recent years more complex models have been developed that take into account heterogeneous rates of evolution at di¡erent sites within genes. This is important because HIV-1 sequences can be seen to evolve in this way (Leitner et al. 1997) . Ignoring this rate heterogeneity leads to an underestimation of the true amount of divergence among sequences and thus an underestimate of the time-depth of the phylogeny . Incorporating gamma-distributed among-site rate variation into the molecular clock analysis pushed the estimate of the common ancestor of the M group back from 1960 to before 1940 . Korber et al. (2000a) have performed the most complete analysis of this question. Analysing envelope gene sequences of HIV-1 isolates from more than 150 individuals, and using a maximum-likelihood model of sequence evolution allowing individual sites to evolve at di¡erent rates, they estimated the common ancestor of the M group at 1931, with a con¢dence interval of 19151 941. Corroboration of the validity of the approach used came with the correct prediction of the date of origin of the ZR59 sample. (See also Yusim et al., this issue.)
DATING AN ABSTRACTION?
If the common ancestor of the HIV-1 M group was a human virus, i.e. occurred after the chimpanzee-tohuman transmission, then the dating results described above clearly contradict the idea that transmission was due to contaminated OPV, since that would have occurred in the late 1950s. In response, the leading proponent of the OPV^AIDS idea has argued that`Dr Korber's work . . . dates an abstraction. It does not tell us if the 1931``last common ancestor'' of HIV-1(M) was a chimp virus or a human virus' (Hooper 2000b). In other words, to sustain the OPV^AIDS hypothesis, Hooper has now suggested that the last common ancestor of the M group was still residing in chimpanzees, and therefore that multiple strains of SIVcpz were transmitted to humans (¢gure 3b). Various lines of evidence from the available data indicate that this suggestion is quite implausible.
If it is argued that the original diversi¢cation of the M group occurred in chimpanzees, the distinct lineages within HIV-1 group M would have arisen in one of two ways. They could represent either diverse members of a quasi-species from a single infected chimpanzee or viruses from numerous infected chimpanzees. Note that an intermediate scenario, where the multiple lineages came from two (or a few) quasi-sp ecies, would not be consistent with the data because there are not two (or a few) distinct clades within the M group.
First, how many distinct viruses would need to have been transmitted ? To be consistent with the time-scale, there must have been at least one for each subtype, of which there are currently ten or more (Peeters & Sharp 2000) . In addition, there are other distinct lineages, as divergent as the current subtypes (Vidal et al. 2000) , which have not been given subtype status because only one strain has thus far been characterized . Furthermore, for whatever number of distinct viruses are hypothesized to have been successfully transmitted, it must be expected that there would have to have been numerous additional strains that, simply by chance, did not become established in the human population or at least have no detected descendants. Thus, one would have to postulate some very large number of divergent viruses (perhaps as many as 50?) in the putatively contaminated vaccines.
Under the single donor scenario, this large number of members of a quasi-species, all showing approximately 25 years' worth of divergence from one another, would need to have been transmitted. This is implausible for two reasons. First, the vast majority of the chimpanzees at Camp Lindi were under four years old (Korber et al. 2000b) . Second, even with a chimpanzee that had been infected for 25 years, a sample from the viral quasispecies would contain strains that had diverged at various times over this period, and perhaps none that had diverged as long as 25 years ago; thus to expect that one would sample only strains that had diverged from one another 25 years earlier is simply unrealistic. Alternatively, under the multiple donor scenario, we would need to invoke a population of chimpanzees with SIVs all dating back to a common ancestor only (but no less than) 25 years earlier. Again, the phylogenetic data for available SIVcpz strains argue strongly against this. Thus this time-gap of around 25 years between the estimated date of the common ancestor of the M group and the period when OPV was administered is much too long for the single donor scenario, but much too short for the multiple donor scenario.
RECOMBINATION
Retroviruses are highly recombinogenic. There is widespread evidence of recombination among HIV-1 strains, both within quasi-species (Vartanian et al. 1991; Howell et al. 1991; Groenink et al. 1992) and involving discrete strains after multiple infections (Robertson et al. , 1997 McCutchan 1998) . It must be expected that this also occurs among strains of SIVcpz. If, as now hypothesized by Hooper (2000b) , the M group of HIV-1 arose through the transmission of multiple strains of SIVcpz, derived from either a single or multiple chimpanzees, we must expect that those strains would have been undergoing recombination prior to their arrival in humans.
Thus, if the putative OPV contamination involved diverse members of a single quasi-species, those strains would have been undergoing recombination in the infected chimpanzee. Alternatively, if the putative OPV contamination involved diverse strains from multiple chimpanzees it would imply a su¤ciently high rate of infection that, combined with chimpanzee behaviour patterns (Goodall 1986; Wrangham et al. 1992) , should have led to instances of multiple infection and as a consequence recombination among divergent SIVcpz strains. Indeed this is known to have occurred among strains of SIVcpz from western equatorial Africa, since HIV-1 group N viruses are descended from a virus that was a recombinant of divergent SIVcpz strains.
However, there is little or no evidence of recombination having occurred during the early divergence of the lineages giving rise to the subtypes within HIV-1 group M. Recombination events deep within the M group phylogeny would be hard to identify (Schierup & Hein 2000) , but the very fact that discrete subtypes can be identi¢ed indicates that recombination must have been rare during this period of early diversi¢cation within the M group. The recombination events that have been identi¢ed have all involved strains subsequent to the establishment of the subtypes. This is as expected if the common ancestor of the M group existed after the transmission of SIVcpz to humans. During the early period of diversi¢ca-tion of the M group, the number of infected people would have been quite small and multiple infection would have been unlikely, so that there would have been little opportunity for recombination among divergent strains. In contrast, the apparent scarcity of recombination during the pre-subtype phase of M group diversi¢cation would be quite unexpected if these viral lineages were still in chimpanzees.
It has been remarked that the three earliest examples of HIV-1 group M for which sequence data are available, namely ZR59, Z321 and MAL, were all multiply recombinant and that the recombination events may have occurred before the transmission to humans (Hooper 2000a (Hooper , p. 1062 . However, there is no evidence for this. First, two of these isolates are not particularly`early' in the context of the time-scale of the subtypes: Z321 was isolated in 1976 from a Zairian woman who had lived in Kinshasa between 1972 and 1976 where she was considered a`free woman' (Nzilambi et al. 1988) , while MAL was probably contracted from a blood transfusion in Zaire in 1981 (Alizon et al. 1986) . Second, and more important, the analyis of the only really early sample, ZR59 from 1959, provided no evidence for the suggestion that it was a recombinant (Zhu et al. 1998) .
Finally, widespread recombination among a group of sequences can a¡ect the estimated time of their common ancestor. In the context of dating the common ancestor of HIV-1 group M, it has been suggested that it is unclear whether recombination would make the introduction date earlier or later ' (Hooper 2000a, p. 870) . This statement is strange: it is clear that recombination would make the date of the common ancestor seem more recent (Schierup & Hein 2000) . Korber et al. (2000a) removed identi¢able inter-subtyp e recombinant sequences from their analyses, but if there were any such strains remaining in the data set the consequence would be that the true date of the common ancestor of the M group would be even earlier than the estimate of 1931.
RATES OF NON-SYNONYMOUS SUBSTITUTION
The pattern of nucleotide substitution on the early branches within the M group of HIV-1 could also be informative about when, i.e. where on the evolutionary tree, transmissions from chimpanzees to humans occurred. The degeneracy of the genetic code implies that, within protein-coding sequences, nucleotide substitutions can be categorized as non-synonymous (or synonymous) depending on whether they a¡ect (or do not a¡ect) the amino-acid sequence encoded. It has often been suggested that the rate of non-synonymous substitutions might increase after cross-species transmission of a pathogen, re£ecting adaptation to the new host. In contrast, synonymous substitutions are expected to be largely neutral, and re£ect only the underlying rate of mutation and replication. Therefore the relative rate of non-synonymous substitution, dN (also referred to as K A ), can be calibrated by comparison with the rate of synonymous substitution, dS (or K S ), using the dN/dS (or K A /K S ) ratio.
Using such an approach, Shpaer & Mullins (1993) reported a correlation between rates of protein evolution and pathogenicity. Speci¢cally, they found higher dN/dS ratios in HIV-1 and SIVmac than in SIVsm and SIVagm, for the gag gene and the segment of env encoding the surface glycoprotein (gp120). Like HIV-1, SIVmac is due to a recent cross-species transmission (although the source of SIVmac was SIVsm from sooty mangabeys, as for HIV-2), and SIVmac causes a severe AIDS-like illness in macaques. In contrast, SIVagm resembles SIVsm insofar as it represents a natural infection of African primates (in this case, African green monkeys) and is not known to cause any disease. However, dN in HIV-2 were not found to be substantially higher than in SIVsm. Rates of evolution in SIVcpz were not investigated at that time. Mindell (1996) reported a lower dS/dN ratio (i.e. a higher dN/dS) for gag and env (gp120) among HIV-1 group M strains than in SIVcpzGab1. These reports suggest that we can look at dN/dS ratios on individual branches within the SIVcpz/HIV-1 phylogeny, to see where within the evolution of HIV-1 the ratio has increased, and so infer which branches involved chimpanzee-to-human transmission.
We have investigated this recently, using a maximumlikelihood approach (Yang 1998) to estimate the values of the dN/dS ratio on each branch within the phylogenetic tree. For each of the gag, pol and env genes, we have found that dN/dS values vary among branches, but that this is not simply correlated with whether the branch re£ects evolution of the virus in chimpanzees or in humans. That is, the dN/dS values are not all higher in HIV-1 than in SIVcpz. Rather, the higher dN/dS values are all found on branches near the tips of the tree, i.e. recent branches can have high dN/dS. The results for the env gene are shown (¢gure 4a): for the gag and pol genes di¡erent values of dN/dS were seen, presumably re£ecting di¡erent levels of constraint on the products of these genes, but the same overall trend of increased dN/dS only on recent branches was observed. These results seem to indicate the shortterm accumulation of slightly deleterious, non-synonymous substitutions that become eliminated over time (perhaps, for example, at the point of transmission between individuals). These results are interesting, but imply that this approach does not immediately reveal when the viruses were subject to cross-sp ecies transmission.
In our earlier attempts to identify viral genetic changes associated with transmission from chimpanzees to humans, the principal region identi¢ed was the part of the envelope gene encoding the V3 loop (Van den Haesevelde et al. 1996; Hahn et al. 2000) . The V3 loop lies on the outside of gp120 and forms part of the binding site used by the virus to engage a cell surface co-receptor during the fusion process (Choe et al. 1996; Wyatt & Sodroski 1998) . V3 also represents a neutralizing antibody binding site (Parren et al. 1999) . Hence the V3 loop is under strong in vivo selection pressures related to alterations in viral tropism (co-receptor choice) and immune evasion (neutralizing antibody escape). It is thus not surprising that amino-acid sequence diversity in this region is much higher among HIV-1 strains than among SIVcpz strains (including SIVcpzAnt), even though in trees based on whole protein sequences the diversity among SIVcpz strains is the higher (¢gure 2). When the dN/dS analysis reported above was applied to V3 loop sequences only, the same overall trend was seen as for entire gag, pol and env gene sequences (¢gure 4b). However, there are two branches showing extremely high dN/dS values (around 0.6) given their depth within the tree (dS to tip values greater than 0.5). These unusually high values come from the branches prior to the common ancestor of group M and the common ancestor of group O. These results suggest that the accelerated rate of V3 evolution, and thus the altered evolutionary pressures associated with a change of host, occurred prior to the common ancestors of group M and O; i.e. that the chimpanzee-tohuman transmissions occurred prior to the common ancestors of groups M and O.
CONCLUSIONS
HIV-1 groups M, N and O represent three distinct cross-species transmissions of SIVcpz, with all of the evidence pointing to western equatorial Africa as the location where these events took place. The common ancestor of HIV-1 group M existed before 1940, with all of the evidence indicating that this virus was already infecting humans at that point. Both of these observations contradict the suggestion that the human viruses arose via contaminated OPVs.
If`natural' transfer can occur through human exposure to infected primate blood or excretions during hunting or other activities, the obvious question that remains is why the AIDS epidemic arose only in the latter half of the 20th century. In this context it is important to distinguish between two stages in the advent of the epidemic. The ¢rst stage is the transmission of SIV to a human. Given the evidence for several transfers of both SIVcpz (giving rise to the three groups of HIV-1) and SIVsm (leading to the multiple subtypes of HIV-2), it seems likely that crossspecies transmission has occurred on a multitude of occasions in the past. The second stage is the successful establishment of an epidemic by the newly arrived virus. It is this second stage that seems new, and most likely re£ects changes in population structure and behaviour in Africa during the 20th century and perhaps medical interventions that provided the opportunity for rapid human-to-human spread of the virus (Chitnis et al. 2000) . It is clear that even in recent times, di¡erent transfers of SIVcpz and SIVsm (the di¡erent groups of HIV-1 and the subtypes of HIV-2) have succeeded to very di¡erent extents, ranging from subtypes of HIV-2 that have only ever been described in a single individual to the M group of HIV-1 that has already infected more than 50 million people worldwide. Ruling out OPV as a viable source of human infection is important because it means that we still do not understand which viral, host and/or environmental factors played a role in sparking the AIDS pandemic.
